Marktgröße und Marktanteil von Neuraminidase-Inhibitoren bis 2025 – 2031
Neuraminidase Inhibitors Drug Market Report Analysis
Neuraminidase Inhibitors Drug Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- GLAXOSMITHKLINE PLC
- GILEAD SCIENCES
- DAIICHI SANKYO
- BIOCRYST LTD
- F. HOFFMANN LA ROCHE
- FOREST PHARMACEUTICALS INC.
- ENDO PHARMACEUTICALS INC.
- BRITANNICA
- SHIONOGI CO
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation
By Arzneimitteltyp
- Oseltamivir
- Zanamivir
- Peramivir
- Laninamivir
By Verabreichungsweg
- parenteral
- nasal und oral
By Vertriebskanal
- Krankenhausapotheke
- Einzelhandelsapotheke
- Online-Apotheke
- Sonstiges
By Geographie
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
Get Free Sample For